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Many studies have suggested that oils high in saturated fatty acids are responsible for the cholesterol-
raising effect of saturated fat. The aim of this study was to compare the effect of palm oil (rich in 
saturated fatty acid) and egusi melon oil (rich in unsaturated fatty acids) on serum and liver lipids and 
their antioxidant status. Lipid profiles, malondialdehyde (MDA) levels and activities of glutathione 
peroxidase (GSH-Px) and glutathione reductase (GSSG-Rx) were determined in serum and liver of rats 
fed a high cholesterol diet for six weeks. Palm oil- and egusi melon-fed rats exhibited improved serum 
and liver lipid profiles and had a more significant reduction in serum and liver MDA levels as compared 
to control rats. Similarly, GSH-Px and GSSG-Rx activities were significantly higher in rats fed palm and 
egusi melon oils compared to the control. It could thus be concluded based on these findings, that 
palm oil and egusi melon improve serum and liver lipid profile in rats fed a high fat diet and their 
consumption could thus offer protection against lipid-related disorders. 
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INTRODUCTION 
 
It is clearly established that long-term consumption of a 
high fat diet accelerates the development of Coronary 
Heart Disease (CHD). Therapeutic agents which control 
the levels of serum cholesterol have proven to be 
effective in the treatment of CHD (Bays and Stein, 2003; 
Linsel-Nitschke and Tall, 2005). While agents exist that 
can modulate circulating levels of cholesterol-carrying 
lipoproteins by inhibiting cholesterol synthesis, these 
agents have little or no effect on the intestinal absorption 
of cholesterol. 
Dietary cholesterol can increase the level of serum 
cholesterol to levels which can place an individual at 
increased risk for the development or exacerbation of 
atherosclerosis (Onyeneke et al., 2007; Oluba et al., 
2008a). CHD increases dramatically as the plasma 
concentration of LDL cholesterol increases (Berg et al., 
1986).  Consequently, the  development  of   methods  for 
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lowering LDL cholesterol levels has become a major 
focus of medical research. The approach of reducing 
dietary cholesterol suffers from two limitations. The first is 
that cholesterol is present in all animal fats and many 
people are unwilling to scarify their preferred diet. The 
second is that the liver and other tissues synthesize 
cholesterol de novo if the dietary supply is inadequate. 
Palm oil (PO), obtained from a tropical plant Elaeis 
guineensis, represents the second largest volume of 
vegetable oil produced in the world. It is rich in saturated 
fatty acids, antioxidant and vitamins and is widely used 
as an oil in diet. An earlier study by Oluba et al. (2008b) 
showed that PO is more hypocholesterolemic than 
soybean oil when both are fed as supplements (5% v/w) 
to a high fat diet in rats. Moreover, crude palm oil is 
considered to be the richest source of carotenoids and 
tocotrienols. The human body uses carotenoids as 
vitamin A. Carotenoids are also believed to enhance 
immune function by a variety of mechanisms, and can 
improve cardiovascular health (Ebong et al., 1999). 
Carotenoids and tocotrienols also play significant roles by 
acting   as   biological  antioxidants, protecting  cells   and 
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tissues from the damaging effect of free radicals. On the 
other hand, egusi melon oil (EMO), obtained from the 
seeds of Citrulus lanatus and used as a common 
component of daily meals in West Africa, is 
predominantly composed of unsaturated fatty acids 
(percentage composition by weight of oil: lauric, 0.21%; 
myristic, 0.78%; palmitic, 13.45%; stearic 13.71%; oleic, 
14.50%; linoleic, 56.94% and linolenic, 0.46%) (Oluba et 
al., 2008c). Based on these findings, we sought to 
investigate whether PO (a saturated fatty acid source) 
and EMO (an unsaturated fatty acid rich source) have the 
same, similar or different effects on serum and tissue lipid 
profiles and their antioxidant activity in rats fed a high fat 
diet.  
 
 
MATERIALS AND METHODS  
 
Collection and preparation of egusi melon seeds sample 
 
The egusi melon seeds used for this study were obtained from a 
local market in Iwaro-Oka Akoko, Ondo State, Nigeria and were 
identified as C. lanatus (egusi melon) by a taxonomist in the 
Department of Crop Science, Faculty of Agriculture, University of 
Benin, Benin City, Edo State, Nigeria. The seeds were screened to 
remove bad ones, shelled manually and further screened. The 
seeds were then dried to constant weight in an oven at 70°C, 
ground using mechanical grinder, put in air-tight containers and 
stored in desiccators for further analyses while some of the seeds 
were subsequently deposited at the herbarium of the Faculty. 
 
 
Oil extraction 
 
Oil from the seeds of egusi melon was extracted by continuous 
extraction in a Soxhlet apparatus (Cehmglass) for 8 h using 
petroleum ether (60 to 80°C boiling range) as solvent according to 
the method of AOAC (1980). At the end of the extraction, the 
extraction solvent was evaporated in a rotary evaporator 
(Cehmglass). The extracted oil was used for feed formulation and 
the remaining stored in a light proof, airtight and moisture proof 
container at -4°C.  
The palm oil sample used for this study was obtained from 
Okitipupa Oil Palm Mill, Okitipupa, Ondo State (Nigeria). The oil 
was stored in a light-proof, airtight and moisture-proof container at -
4°C. 
 
 
Experimental animals 
 
Six-week old Male Wistar rats having a mean weight of 72.4 ± 4.8 g 
were obtained from the Nigerian Institute of Medical   Research, 
Lagos   and   housed   individually  in stainless steel cages with 
raised wire flour in an environment of 24 to 25°C, 50 to 60% relative 
humidity and a 12 h light-dark cycle. Rats were acclimated to 
individual cages for one week before the diet treatment. During the 
acclimatization period, the rats were fed with a commercial rat chow 
(Guinea Feed Ltd, Nigeria) and water ad libitum. All experimental 
protocols complied with the NIH guidelines (NRC, 1985). 
 
 
Diets 
 
At the end of the first week, animals were assigned by weight into 
three  groups  of  ten   each   (n =  10/group)   and   placed   on  the 
 
 
 
 
experimental diet for six weeks. The diet groups included control 
(CO), palm oil (PO), and egusi melon oil (EMO). The experimental 
diets were prepared according to the recommendations of the 
America Institute of Nutrition (AIN) and contained (% weight) casein 
20%, fat 10%, vitamin mixture (AIN-76) 3.5%, choline bitartrate 
(BDH, England) 0.2%, DL-methionine (Sigma, England) 0.3%, corn 
starch 15% and sucrose 100%. In addition, fresh palm oil (5%) and 
egusi melon oil (5%) were added and mixed with PO and EMO 
diets, respectively. 
 
 
Experimental design 
 
Before the commencement of the experiment, animals were 
deprived food overnight but allowed access to water ad libitum. Five 
rats from each group were then sacrificed and blood and liver 
samples taken to establish the baseline levels of the studied 
parameters. At the end of the diet treatment, the remaining animals 
in each group were fasted overnight and sacrificed by decapitation. 
Animals were allowed free access to food and water for the 
duration of the study. Diet consumption and body weight were 
measured weekly, correcting for food spillage.  
 
 
Serum preparation 
 
At pre- and post- diet treatment periods, about 2 ml blood samples 
were collected from each animal by cardiac puncture into plain 
tubes. The blood was allowed to clot at room temperature for 1 h, 
and then centrifuged at 3000 g for 10 min with the serum separated 
into plain tubes and frozen at -20°C until analysis. 
 
 
Liver lipid 
 
Total lipids were extracted from the liver according to Folch et al. 
(1957).  
 
 
Cytosolic and microsomal fractions 
 
Liver cytosolic and microsomal fractions were prepared by the 
method of Speir and Wattenberg (1975). Briefly, rat livers were 
immediately removed, washed in ice cold 1.15% KCl solution, 
blotted, weighed, cut into small pieces in 1.15% KCl at a volume of 
3 ml of KCl per gram liver and homogenized in 4 volumes of the 
homogenizing buffer (pH 7.4) using a Potterelvegin homogenizer. 
The homogenate was centrifuged at  900 g at 4°C for 20 min in a 
Sorvall RC-5B superspeed centrifuge. The supernatant was 
pipetted into a clean centrifuge tube and centrifuged further at 
105,000 g at 4°C in a Beckman L5- 50B ultracentrifuge for 45 min. 
The cytosol was used for GSH-Px and GSSG-Rx activities. 
 
 
Lipid assays 
 
Total cholesterol (TC), HDL-cholesterol and triacylglycerol (TAG) 
were quantified using enzymatic kit (Randox Laboratories, San 
Francisco, USA) methods according to the manufacturers 
instructions. Non HDL-cholesterol was calculated by the Friedwald 
formula. 
 
Estimation of lipid peroxidation products: Lipid peroxidation was 
estimated in the liver by assessing malondialdehyde (MDA) levels 
using the Thiobarbituric Acid Reactive Substances (TBARS) 
method of Varshney and Kale (1990). 
 
Enzyme assay: Glutathione   peroxidase  (GSH-Px)   activity   was 
  
 
 
Table 1. Weekly body weight gain (g). 
 
Time (Week) CO PO EMO 
0 72.0 ± 8.4 72.4 ± 5.5 72.2 ± 9.0 
1 79.5 ± 10.3 79.2 ± 4.8 79.0 ± 12.5 
2 86.4 ± 6.2 85.7 ± 9.0 85.2 ± 8.2 
3 97.7 ± 17.5 94.5 ± 5.2 95.5 ± 10.6 
4 125.1 ± 20.4 109.2 ± 17.0* 114.2 ± 20.2* 
5 148.5 ± 11.9 129.5 ± 10.7* 131.8 ± 15.0* 
6 164.3 ± 32.5 141.3 ± 8.9* 154.2 ± 22.2* 
 
Values are mean ± SEM of five determinations. CO, control group; PO, 
palm oil group; EMO, egusi melon group. * Significantly different (p < 
0.05) from control (CO). 
 
 
 
measured according to the method described by Rotruck et al. 
(1973). Glutathione reductase (GSSG-Rx) activity was measure by 
the method of Racker (1955) with slight modifications. The assay 
mixture consisted of 0.1 M phosphate buffer (pH 7.6), 0.1 mM 
NADPH, 0.5 mM EDTA, 1 mM GSSG and cytosol in a final volume 
of 1.0 ml. Enzyme activity was quantitated at 29°C by measuring 
the disappearance of NADPH at 340 nm. Specific activity for 
GSSG-Rx was defined as the oxidation of 1 µmol of NADPH per 
min per mg protein. Protein estimation was conducted by Lowry et 
al.’s (1951) method. 
 
 
Statistical analyses 
 
Data are mean ± SEM of five determinations. Statistical analysis 
was done by Analysis of Variance (ANOVA) and Duncan’s Multiple 
Range Tests (DMRT) using SPSS 10.0. p values of < 0.05 control 
was considered significant. 
 
 
RESULTS  
 
No significant differences in food intake (23.1 ± 3.2 g/day) 
among the three diet groups during the study. At the end 
of the experiment, rats fed PO and EMO diets gained 
less weight than rats fed control diet. However, rats fed 
PO diet gained less weight than those fed EMO diet (p < 
0.05) (Table 1). The difference in weight gain could be 
attributed to the low total body fat content in the group fed 
PO in comparison with the group fed EMO (Table 1).  
 
 
Serum lipids 
 
Serum TC concentrations was about 30 and 20% 
significantly lower (p < 0.001) in the groups fed PO and 
EMO respectively than in the CO group. Although rats fed 
PO had higher reduction than rats fed EMO diet in serum 
TC, the difference was not significant (p > 0.1) (Table 2). 
Serum TG concentrations were about 30% significantly 
lower in both PO and EMO fed rats compared to CO 
group. No significant difference (p > 0.1) was observed in 
serum TG levels between PO and EMO groups (Table 2). 
No significant differences (p > 0.1) in serum HDL-C  were  
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detected among the three groups at the end of  the study. 
However, serum nHDL-C was significantly lower (p < 
0.001) in both PO and EMO than in the CO group. A non-
significant (p > 0.1) lower concentration in serum nHDL-C 
was also observed in PO compared to EMO group (Table 
2). 
 
 
Liver lipids 
 
Analysis of liver lipid composition showed that animals in 
PO and EMO groups had significantly lower (p < 0.001) 
levels of TC compared to those in the CO group at the 
end of the study. Though TC concentration was lower in 
the PO group than in the EMO group, the decrease is not 
significant (p > 0.1) (Table 3). Hepatic TAG 
concentrations were significantly (p < 0.001) reduced in 
both PO and EMO rats compared to rats in the CO group. 
The decreased level observed in liver TAG in PO rats 
compared to EMO rats was not significant (p > 0.1) 
(Table 3). Lipoprotein fraction analysis of the liver 
revealed a significant increase in HDL-C in PO group 
compared to CO group and a non-significant increase (p 
> 0.1) in the EMO group compared to the CO group 
(Table 3). The nHDL-C levels were significantly reduced 
in both PO and EMO groups compared to CO group. The 
nHDL-C was also significantly reduced (p < 0.001) in the 
PO group compared to the EMO group (Table 3). 
 
 
Antioxidant status 
 
Serum concentration of MDA was significantly reduced in 
both PO and EMO groups compared to the CO group. A 
significantly lower value was also observed when MDA 
level in the PO group was compared to the EMO group 
(Table 4). However, serum activities of GSH-Px and 
GSSG-Rx were significantly elevated in both PO and 
EMO groups compared to the CO group. A significantly 
higher difference was also observed when activities of 
both enzymes in PO rats were compared to those of 
EMO animals (Table 4). Liver concentrations of MDA 
were significantly lower in both PO and EMO groups 
when compared to the CO group. However, liver activities 
of GSH-Px and GSSG-Rx were significantly elevated in 
both PO and EMO groups compared to the CO group. A 
non-significantly (p < 0.1) higher difference was also 
observed when activities of both enzymes in PO rats 
were compared to those of EMO animals (Table 4). 
 
 
DISCUSSION  
 
Body weight gain differed despite the similar cumulative 
energy intake throughout the study in the three groups. 
The difference in weight gain could be attributed to the 
low total body fat content in the group fed PO in 
comparison  with   the  group fed  EMO  (Tables 2 and 3).  
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Table 2. Serum lipid composition and serum cholesterol lipoprotein fractions (mg/dl). 
 
TC (mg/dl) TAG (mg/dl) Time (Week) 
CO PO EMO CO PO EMO 
0 52.3 ± 2.2 54.0 ± 3.0 50.8 ± 5.1 21.0 ± 1.3 21.7 ± 1.2 2.5 ± 1.0 
6 104.6 ± 12.2 70.4 ± 8.2* 81.5 ± 5.5* 42.5 ± 2.3 30.3 ± 1.2* 31.1 ± 2.2* 
       
 
HDL-C nHDL-C 
 
CO PO EMO CO PO EMO 
0 6.3 ± 1.2 7.0 ± 1.2 6.1 ± 1.5 46.0 ± 5.3 47.0 ± 3.6 44.7 ± 2.2 
6 11.6 ± 2.0 10.6 ± 1.5 9.8 ± 1.1 93.0 ± 10.5 59.8 ± 7.2* 71.7 ± 3.8* 
  
CO, control group; PO, palm oil group; EMO, egusi melon group; TC, total cholesterol; TAG, triacyl glycerol; HDL-C, 
high-density lipoprotein cholesterol; nHDL-C, non high-density lipoprotein cholesterol.*Significantly different (p < 
0.05) from control (CO). 
 
 
 
Table 3. Liver lipid composition (mg/g wet tissue) and lipid cholesterol lipoprotein fractions (mg/dl). 
 
TC TG Time (Week) 
CO PO EMO CO PO EMO 
0 1.2 ± 0.2 1.2 ± 0.2 1.2 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 
6 15.5 ± 3.6 8.4 ± 0.5* 10.8 ± 2.6* 8.8 ± 2.2 5.4 ± 1.5* 6.2 ± 1.3* 
       
 
HDL-C nHDL-C 
 
CO PO CO PO CO PO 
0 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.2 
6 1.7 ± 0.1 2.4 ± 0.2* 2.0 ± 0.2 13.8 ± 1.2 6.0 ± 0.5* 8.8 ± 1.2* 
 
CO, control group; PO, palm oil group; EMO, egusi melon group; TC, total cholesterol; TG, triacyl glycerol; 
high-density lipoprotein cholesterol; nHDL-C, non high-density lipoprotein cholesterol. *Significantly different 
(p < 0.05) from control (CO). 
 
 
 
Cholesterol  feeding   has  often   been   used  to  elevate 
serum cholesterol concentration in studying the etiology 
of hypercholesterolemia related metabolic disturbances 
such as atherosclerosis. In this study, the elevated serum 
and liver TC and TG concentrations following the 
consumption of a high cholesterolemic control diet were 
similar to the responses reported in rats fed diets with 
similar amounts of cholesterol (Onyeneke et al., 2007; 
Oluba et al., 2008a). It is observed from this study that 
palm oil, a saturated fatty acid - rich oil, better improves 
serum lipid profile than egusi melon oil. According to a 
report by Oluba et al. (2008c), egusi melon oil like 
soybean oil, is predominantly composed of unsaturated 
fatty acids especially linoleic acid. The results of this 
study invalidate the general misconception that oils rich in 
saturated fatty acid increase serum cholesterol compared 
to those rich in unsaturated fatty acids. Data generated in 
this study are in accordance with the findings of Oluba et 
al. (2008b) which show that palm oil lowers serum TC 
and TG compared to soybean oil when both are fed as 
supplements to a high cholesterol diet in rats. Similarly, 
Scholtz et al. (2004) in a separate study reported that 
palm oil lowers serum TC and nHDL-C concentrations 
than coconut oil.  
Another interesting finding from this study is the effect 
of palm oil and egusi melon oil on both serum and liver 
antioxidant status. Cholesterol inclusion in the diet has 
been reported to decrease the circulating levels of insulin 
and serum glutathione (Scholtz et al., 2004), thus 
predisposition to tissue lipid peroxidation. The elevated 
concentrations of tissue TC, TG and nHDL-C following a 
high cholesterol diet presumably could increase the 
susceptibility of tissues to lipid peroxidation unless 
adequate amounts of antioxidants are present. Thus, the 
observed decreases in serum and liver MDA 
concentrations and increases in GSH-Px and GSSG-Rx 
activity (which are important lipid peroxide decomposing 
enzymes in rats) could be attributed to the 
hypocholesterolemic effect of these oils in the serum and 
liver. 
Several mechanisms have been advanced to explain 
the unexpected hypocholesterolemic action of palm oil. 
Of importance is its rich content of the antioxidant, 
tocotrienols. Studies have confirmed that tocotrienols 
inhibit cholesterol synthesis in vivo (Karaji-Bani et al., 
2006), thus enhancing the receptor-mediated transport of 
serum cholesterol to the liver. Tocotrienols could also 
participate in the clearance of lipid peroxides  which  may
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Table 4. Serum and liver antioxidant status indicators.  
 
Serum 
MDA GSH-Px GSSG-Rx Time (Week) 
CO PO EMO CO PO EMO CO PO EMO 
0 0.8 ± 0.2 0.8 ± 0.2 0.9 ± 0.2 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 
6 5.6 ± 0.4 2.7 ± 0.5* 3.2 ± 1.1* 3.5 ± 1.0 0.8 ± 0.2* 1.5 ± 0.4* 1.2± 0.2 0.6 ± 0.2* 1.0 ± 0.2* 
          
Liver 
 MDA (mM/cm3) GSH-Px (mol NADPH/min/mgprotein) GSSG-RX (µmol NADPH/min/mg protein) 
 CO PO EMO CO PO EMO CO PO EMO 
0 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 
6 10.2 ± 3.7 5.7 ± 1.2* 6.5 ± 2.0* 2.8 ± 1.0 4.2 ± 1.2* 3.9 ± 1.2* 2.2 ± 0.2 3.9 ± 0.5* 2.7 ± 0.2* 
 
CO, control group; PO, palm oil group; EMO, egusi melon group; MDA, malondildehyde; GSH-Px, glutathione peroxidase; GSSG-Rx, glutathione reductase. *Statistically different 
(p < 0.05) from control (CO). 
 
 
 
be generated as a result of cholesterol feeding. 
Human studies have also confirmed that palm oil 
tocotrienols have the ability to reverse the 
blockage of carotid artery and platelet aggregation 
(the clumping together of cells) thereby reducing 
the risk of stroke, arteriosclerosis, and ischemic 
heart disease (Chow, 1992). On the other hand, 
the effect of egusi melon (though has not received 
much attention in terms of its nutritional potential) 
on serum cholesterol may be attributed to its rich 
content of essential fatty acids. Since the results 
obtained form this study correlate with those 
obtained using human studies, it therefore infers 
that these results (from this study) can be 
explored in humans.  
In conclusion, the results of this study showed 
that palm oil and egusi melon oil improve serum 
and liver lipid profiles and offer better protection 
against resultant lipid peroxides from consumption 
of high fat diet. 
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